1xh3: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Human HLA-B*3501 binds an antigenic peptide of 14-aa length derived from, an alternative reading frame of M-CSF with high affinity. Due to its, extraordinary length, the exact HLA binding mode was unpredictable. The, crystal structure of HLA-B*3501 at 1.5 A shows that the N and C termini of, the peptide are embedded in the A and F pockets, respectively, similar to, a peptide of normal length. The central part of the 14-meric peptide, bulges flexibly out of the groove. Two variants of the alternative reading, frame of M-CSF peptide substituted at P2 or P2 and P9 with Ala display, weak or no T cell activation. Their structure differs mainly in, flexibility and conformation from the agonistic peptide. Moreover, the, variants induce subtle changes of MHC alpha-helical regions implicated as, critical for TCR contact. The TCR specifically recognizing this, peptide/MHC complex exhibits CDR3 length within the normal range, suggesting major conformational adaptations of this receptor upon, peptide/MHC binding. Thus, the potential antigenic repertoire recognizable, by CTLs is larger than currently thought.
Human HLA-B*3501 binds an antigenic peptide of 14-aa length derived from an alternative reading frame of M-CSF with high affinity. Due to its extraordinary length, the exact HLA binding mode was unpredictable. The crystal structure of HLA-B*3501 at 1.5 A shows that the N and C termini of the peptide are embedded in the A and F pockets, respectively, similar to a peptide of normal length. The central part of the 14-meric peptide bulges flexibly out of the groove. Two variants of the alternative reading frame of M-CSF peptide substituted at P2 or P2 and P9 with Ala display weak or no T cell activation. Their structure differs mainly in flexibility and conformation from the agonistic peptide. Moreover, the variants induce subtle changes of MHC alpha-helical regions implicated as critical for TCR contact. The TCR specifically recognizing this peptide/MHC complex exhibits CDR3 length within the normal range, suggesting major conformational adaptations of this receptor upon peptide/MHC binding. Thus, the potential antigenic repertoire recognizable by CTLs is larger than currently thought.


==Disease==
==Disease==
Line 16: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Eynde, B.J.van.den.]]
[[Category: Eynde, B J.van den.]]
[[Category: Hecht, H.J.]]
[[Category: Hecht, H J.]]
[[Category: Herrmann, H.]]
[[Category: Herrmann, H.]]
[[Category: Janke, V.]]
[[Category: Janke, V.]]
Line 26: Line 26:
[[Category: immune system]]
[[Category: immune system]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:09:17 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:54:42 2008''